Heart failure is a common, costly and potentially fatal condition commonly caused by cardiac cells depletion. Current therapies are aimed at protecting surviving cardiomyocytes, but they are unable to produce cardiac regeneration. Tissue engineered cardiac patches seem promising as cardiac repair tools, but they still pose many limitations as they do not mimic in vivo behavior. Recently, the use of flexible membranes for cardiac cell culture has been suggested as determinant in cardiomyocytic properties. The goal of this study is to compare for the first time key cardiomyocyte functional properties for cardiac repair such as proliferation, migration and displacement, and electrophysiological properties of HL-1 cardiac cell line in two diffe...
Summary: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise f...
Heart failure is initiated by an index event, after which heart function progressively and irreversi...
We hypothesized that clinically sized (1-5 mm thick),compact cardiac constructs containing physiolog...
Heart failure is a common, costly and potentially fatal condition commonly caused by cardiac cells d...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
One of the major challenges in drug development is the development of a drug-screening model that cl...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Cardiac tissue engineering to replace damaged areas of the postmitotic heart is still presented with...
Thesis (Sc.D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2000.Includes ...
Biomaterials to be used as cell delivery systems for cardiac tissue engineering should be able to co...
Engineered cardiac tissue models become increasingly important for understanding normal and diseased...
Conductive and electroactive polymers have the potential to enhance engineered cardiac tissue functi...
The inability of the myocardium to regenerate after injury plus the inadequate number of available h...
In native conditions, cardiac cells must continuously comply with diverse stimuli necessitat-ing a p...
Summary: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise f...
Heart failure is initiated by an index event, after which heart function progressively and irreversi...
We hypothesized that clinically sized (1-5 mm thick),compact cardiac constructs containing physiolog...
Heart failure is a common, costly and potentially fatal condition commonly caused by cardiac cells d...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
One of the major challenges in drug development is the development of a drug-screening model that cl...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Cardiac tissue engineering to replace damaged areas of the postmitotic heart is still presented with...
Thesis (Sc.D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2000.Includes ...
Biomaterials to be used as cell delivery systems for cardiac tissue engineering should be able to co...
Engineered cardiac tissue models become increasingly important for understanding normal and diseased...
Conductive and electroactive polymers have the potential to enhance engineered cardiac tissue functi...
The inability of the myocardium to regenerate after injury plus the inadequate number of available h...
In native conditions, cardiac cells must continuously comply with diverse stimuli necessitat-ing a p...
Summary: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise f...
Heart failure is initiated by an index event, after which heart function progressively and irreversi...
We hypothesized that clinically sized (1-5 mm thick),compact cardiac constructs containing physiolog...